https://www.selleckchem.com/pr....oducts/Pyroxamide(NS
TTP is a rare, life threatening condition, with an annual incidence of 3-11 cases per million people. A deficiency of a vWF multimer cleaving protein, ADAMTS13 is the cause of the condition. Quick accurate diagnosis is crucial in the safe effective treatment of individuals presenting with this condition. First line treatment is the removal of the resulting ulta-large vWF multimers left in the circulation by the lack of ADAMTS13 immunosuppression of antibodies against ADAMTS13. In the last 3 years, introd
پسند
تبصرہ
بانٹیں
